1
|
Kanagalingam G, Dulymamode KN, Jafroodifar A, Huda SA, May A, Masood U, John S. Enlarging Liver Mass: Inflammatory Pseudotumor in a Patient With Polymyalgia Rheumatica. J Investig Med High Impact Case Rep 2022; 10:23247096211070387. [PMID: 35038943 PMCID: PMC8961211 DOI: 10.1177/23247096211070387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Inflammatory pseudotumors of the liver are rare, non-neoplastic liver tumors. Due to the
nonspecific clinical presentation, imaging features, and histopathological findings, they
can mimic malignant tumors requiring invasive diagnostics. We present a case of a
61-year-old female patient with a history of type 2 diabetes mellitus, hypothyroidism,
hyperlipidemia, and polymyalgia rheumatica who had initially presented with abdominal pain
for 3 weeks. Further workup showed normal liver chemistries and tumor markers: AFP and CA
19-9. Magnetic resonance imaging (MRI) of the abdomen showed a segment 6 lesion measuring
4.1 × 4.0 × 3.7 cm. A liver biopsy then confirmed the diagnosis of an inflammatory
pseudotumor of the liver with negative IgG4. On follow-up imaging, a rapid growth of this
liver lesion was noted. Laparoscopy was done but did not show any distinct liver lesion.
Follow-up imaging confirmed a decrease in the size of the mass. Interestingly, the patient
had been on a higher dose of steroids for her polymyalgia rheumatic leading up to the
follow-up imaging. This is the first case of an inflammatory pseudotumor of the liver in a
patient with polymyalgia rheumatica. With this case, we would like to increase the
awareness for inflammatory pseudotumors of the liver as a differential diagnosis of liver
lesions in patients with underlying autoimmune disorders.
Collapse
Affiliation(s)
| | | | - Abtin Jafroodifar
- Department of Radiology, SUNY Upstate Medical University, Syracuse, NY, USA
| | - Syed A Huda
- Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY, USA
| | - Adriana May
- Department of Pathology, SUNY Upstate Medical University, Syracuse, NY, USA
| | - Umair Masood
- Department of Gastroenterology, SUNY Upstate Medical University, Syracuse, NY, USA
| | - Savio John
- Department of Gastroenterology, SUNY Upstate Medical University, Syracuse, NY, USA
| |
Collapse
|
2
|
Ishii-Kitano N, Enomoto H, Nishimura T, Aizawa N, Shibata Y, Higashiura A, Takashima T, Ikeda N, Yuri Y, Fujiwara A, Yoshihara K, Yoshioka R, Kawata S, Ota S, Nakano R, Shiomi H, Hirota S, Kumabe T, Nakashima O, Iijima H. Multiple Inflammatory Pseudotumors of the Liver Demonstrating Spontaneous Regression: A Case Report. Life (Basel) 2022; 12:life12010124. [PMID: 35054517 PMCID: PMC8779591 DOI: 10.3390/life12010124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2021] [Revised: 01/12/2022] [Accepted: 01/14/2022] [Indexed: 11/24/2022] Open
Abstract
Inflammatory pseudotumor (IPT) of the liver is a rare benign disease. IPTs generally develop as solitary nodules, and cases with multiple lesions are uncommon. We herein report a case of multiple IPTs of the liver that spontaneously regressed. A 70-year-old woman with a 10-year history of primary biliary cholangitis and rheumatoid arthritis visited our hospital to receive a periodic medical examination. Abdominal ultrasonography revealed multiple hypoechoic lesions, with a maximum size of 33 mm, in the liver. Contrast-enhanced computed tomography revealed low-attenuation areas in the liver with mild peripheral enhancement at the arterial and portal phases. We first suspected metastatic liver tumors, but fluorodeoxyglucose positron emission tomography, magnetic resonance imaging and contrast-enhanced ultrasonography suggested the tumors to be inconsistent with malignant nodules. A percutaneous biopsy showed shedding of liver cells and abundant fibrosis with infiltration of inflammatory cells. Given these findings, we diagnosed the multiple tumors as IPTs. After careful observation for two months, the tumors almost vanished spontaneously. Physicians should avoid a hasty diagnosis of multiple tumors based solely on a few clinical findings, and a careful assessment with various imaging modalities should be conducted.
Collapse
Affiliation(s)
- Noriko Ishii-Kitano
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Hirayuki Enomoto
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
- Correspondence:
| | - Takashi Nishimura
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
- Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan; (Y.S.); (A.H.)
| | - Nobuhiro Aizawa
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Yoko Shibata
- Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan; (Y.S.); (A.H.)
| | - Akiko Higashiura
- Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan; (Y.S.); (A.H.)
| | - Tomoyuki Takashima
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Naoto Ikeda
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Yukihisa Yuri
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Aoi Fujiwara
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Kohei Yoshihara
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Ryota Yoshioka
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Shoki Kawata
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Shogo Ota
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Ryota Nakano
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Hideyuki Shiomi
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
| | - Seiichi Hirota
- Department of Surgical Pathology, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan;
| | | | - Osamu Nakashima
- Department of Clinical Laboratory Medicine, Kurume University Hospital, Kurume 830-0011, Fukuoka, Japan;
| | - Hiroko Iijima
- Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-cho 1-1, Nishinomiya 663-8501, Hyogo, Japan; (N.I.-K.); (T.N.); (N.A.); (T.T.); (N.I.); (Y.Y.); (A.F.); (K.Y.); (R.Y.); (S.K.); (S.O.); (R.N.); (H.S.); (H.I.)
- Ultrasound Imaging Center, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan; (Y.S.); (A.H.)
| |
Collapse
|
3
|
Calistri L, Maraghelli D, Nardi C, Vidali S, Rastrelli V, Crocetti L, Grazioli L, Colagrande S. Magnetic resonance imaging of inflammatory pseudotumor of the liver: a 2021 systematic literature update and series presentation. Abdom Radiol (NY) 2022; 47:2795-2810. [PMID: 35648207 PMCID: PMC9300573 DOI: 10.1007/s00261-022-03555-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2022] [Revised: 05/07/2022] [Accepted: 05/09/2022] [Indexed: 01/18/2023]
Abstract
PURPOSE Inflammatory pseudotumors of the liver (IPTL) are not exceptional benign lesions with various etiologies, histology, and imaging appearances. The incomplete knowledge of this pathology and the wide polymorphism sometimes resembling malignancy often induce long and expensive diagnostic flow, biopsy and occasionally unnecessary surgery. We propose a systematic revision of MRI literature data (2000-2021) with some narrative inserts and 10 new complete MRI cases, with the aim of organizing the data about IPTL and identifying some typical features able to improve its diagnosis from imaging. METHODS We performed a systematic revision of literature from 2000 to 2021 to obtain MRI features, epidemiological, and clinical data of IPTL. The basic online search algorithm on the PubMed database was "(pseudotumor) AND (liver) AND (imaging)." Quality assessment was performed using both scales by Moola for case report studies and by Munn for cross-sectional studies reporting prevalence data. A case-based retrospective study by collecting patients diagnosed with IPTL from three different university hospitals from 2015 to 2021 was done as well. Only cases with MR examinations complete with T1/T2/contrast-enhanced T1/Diffusion-Weighted (W) images and pathology-proven IPTL were selected. RESULTS After screening/selection 38 articles were included for a total of 114 patients. In our experience we selected 10 cases for a total of 16 IPTLs; 8 out of 10 patients underwent at least 1 MRI follow-up. Some reproducible and rather typical imaging findings for IPTL were found. The targetoid aspect of IPTL is very frequent in our experience (75% on T1W, 44% on T2W, 81% on contrast-enhanced T1W (at least one phase), 100% on Diffusion-W images) but is also recurrent in the literature (6% on T1W, 31% on T2W, 51% on CE-T1W (at least one phase), 18% on Diffusion-W images, and 67% on hepatobiliary phase). In our experience, Apparent Diffusion Coefficient map values were always equal to or higher than those of the surrounding parenchyma, and at MRI follow-up, nodule/s disappeared at first/second control, in six patients, while in the remaining 2, lesions persisted with tendency to dehydration. CONCLUSION A targetoid-like aspect of a focal liver lesion must raise diagnostic suspicion, especially if IgG4-positive plasma is detected. MRI follow-up mainly shows the disappearance of the lesion or its reduction with dehydration.
Collapse
Affiliation(s)
- Linda Calistri
- Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134 Florence, Italy
| | - Davide Maraghelli
- Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134 Florence, Italy
| | - Cosimo Nardi
- Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134 Florence, Italy
| | - Sofia Vidali
- Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134 Florence, Italy
| | - Vieri Rastrelli
- Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134 Florence, Italy
| | - Laura Crocetti
- Clinical and Translational Science Research Department - Division of Interventional Radiology, Cisanello University Hospital, Bldg 30, Via Paradisa 2, 56124 Pisa, Italy
| | - Luigi Grazioli
- Department of Radiology, University of Brescia “Spedali Civili”, P. le Spedali Civili 1, Brescia, Italy
| | - Stefano Colagrande
- Department of Experimental and Clinical Biomedical Sciences, Radiodiagnostic Unit n. 2, University of Florence - Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134 Florence, Italy
| |
Collapse
|
4
|
Maruno M, Imai K, Nakao Y, Kitano Y, Kaida T, Mima K, Hayashi H, Yamashita YI, Mikami Y, Baba H. Multiple hepatic inflammatory pseudotumors with elevated alpha-fetoprotein and alpha-fetoprotein lectin 3 fraction with various PET accumulations: a case report. Surg Case Rep 2021; 7:107. [PMID: 33913027 PMCID: PMC8081814 DOI: 10.1186/s40792-021-01188-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Accepted: 04/18/2021] [Indexed: 01/08/2023] Open
Abstract
Background Hepatic inflammatory pseudotumor (IPT) is a rare, benign, tumor-like lesion. Because there are no characteristic laboratory markers or radiological features, hepatic IPT is often misdiagnosed as a malignant neoplasm such as hepatocellular carcinoma (HCC). Case presentation A 68-year-old man with liver dysfunction due to chronic hepatitis C virus infection and alcoholic liver disease presented with hepatic tumors in segments III and VIII. The levels of serum alpha-fetoprotein (AFP) and its Lens culinaris agglutinin-reactive fraction, AFP lectin 3 (AFP-L3), were elevated to 822.8 ng/ml and 75.2%, respectively. The tumor showed contrast enhancement on contrast-enhanced computed tomography and various accumulation on positron emission tomography. Based on these biological and imaging features, HCC was suspected, and we performed laparoscopic partial hepatectomy for these two tumors. Pathological diagnosis revealed that both tumors were hepatic IPTs with no malignant characteristics. After hepatectomy, the serum AFP and AFP-L3 levels decreased to the normal range. Conclusion We report a very rare case of hepatic IPT with elevated serum AFP and AFP-L3, mimicking HCC. Clinicians should include this rare neoplasm in the differential diagnoses of hepatic tumors even when the serum markers for HCC are elevated.
Collapse
Affiliation(s)
- Masataka Maruno
- Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan
| | - Katsunori Imai
- Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
| | - Yosuke Nakao
- Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan
| | - Yuki Kitano
- Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan
| | - Takayoshi Kaida
- Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan
| | - Kosuke Mima
- Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan
| | - Hiromitsu Hayashi
- Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan
| | - Yo-Ichi Yamashita
- Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan
| | - Yoshiki Mikami
- Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Japan
| | - Hideo Baba
- Department of Gastroenterological Surgery, Kumamoto University Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto, 860-8556, Japan
| |
Collapse
|